|
INTRODUCTION |
XVII |
|
REASON FOR DOING THE STUDY |
XVII |
|
STUDY GOALS AND OBJECTIVES |
XVII |
|
THE CONTRIBUTION OF THIS STUDY AND FOR WHOM IT IS INTENDED |
XVII |
|
SCOPE AND FORMAT OF THE REPORT |
XVIII |
|
METHODOLOGY AND INFORMATION SOURCES |
XVIII |
|
BCC WORK CREDENTIALS |
XVIII |
|
RELATED BCC REPORTS |
XVIII |
|
BCC ON-LINE SERVICES |
XIX |
|
DISCLAIMER |
XX |
|
SUMMARY |
XXI |
|
SUMMARY TABLE: U.S. SEPARATIONS FOR BIOTECHNOLOGY MARKET VALUE, THROUGH 2008 ($ MILLIONS) |
XXII |
|
SUMMARY FIGURE: U.S. SEPARATIONS FOR BIOTECHNOLOGY MARKET VALUE, THROUGH 2008 ($ MILLIONS) |
XXIII |
|
OVERVIEW OF BIOTECHNOLOGY SEPARATIONS |
1 |
|
MARKET VALUE |
1 |
|
FIGURE 1 U.S. BIOTECH SEPARATIONS MARKET SHARES BY GEOGRAPHICAL REGION, 2003 (%) |
2 |
|
TABLE 1 U.S. BIOTECH SEPARATIONS MARKET VALUE BY GEOGRAPHICAL REGION, 2003 |
3 |
|
FIGURE 2 U.S. BIOTECH SEPARATIONS MARKET SHARES BY TYPE, 2003 |
4 |
|
TABLE 2 U.S. BIOTECH SEPARATIONS MARKET VALUE BY TYPE, 2003 |
4 |
|
LIQUID CHROMATOGRAPHY |
5 |
|
FIGURE 3 U.S. BIOTECH LC TECHNIQUES MARKET SHARES BY TYPE, 2003 |
5 |
|
TABLE 3 U.S. BIOTECH LC TECHNIQUES MARKET VALUE BY TYPE, 2003 ($ MILLIONS) |
6 |
|
CENTRIFUGATION |
6 |
|
FIGURE 4 U.S. BIOTECH CENTRIFUGATION MARKET SHARES BY TYPE, 2003 (%) |
7 |
|
TABLE 4 U.S. BIOTECH CENTRIFUGATION MARKET VALUE BY TYPE, 2003 ($ MILLIONS) |
8 |
|
MEMBRANE FILTRATION |
8 |
|
FIGURE 5 U.S. BIOTECH MEMBRANE FILTRATION MARKET SHARES BY TYPE, 2003 |
9 |
|
TABLE 5 U.S. BIOTECH MEMBRANE FILTRATION MARKET VALUEBY TYPE, 2003 ($ MILLIONS) |
9 |
|
ELECTROPHORESIS |
10 |
|
FIGURE 6 U.S. BIOTECH ELECTROPHORESIS MARKET SHARES BY TYPE, 2003 (%) |
10 |
|
TABLE 6 U.S. BIOTECH ELECTROPHORESIS MARKET VALUE BY TYPE, 2003 ($ MILLIONS) |
11 |
|
NICHE TECHNOLOGIES |
11 |
|
FIGURE 7 U.S. BIOTECH NICHE SEPARATION TECHNOLOGIES MARKET SHARES BY TYPE, 2003 (%) |
12 |
|
TABLE 7 U.S. BIOTECH MISCELLANEOUS MARKET VALUE BY TYPE, 2003 ($ MILLIONS) |
13 |
|
MOLECULAR SEPARATIONS |
13 |
|
SEPARATION STEPS IN BIOSEPARATIONS |
14 |
|
FIGURE 8 GENERAL SCHEME OF A BIOTECH SEPARATION |
15 |
|
STEPS IN PROCESSING BIOLOGICALS |
15 |
|
TABLE 8 PROCESSING STEPS AND TECHNIQUES |
16 |
|
STRUCTURE OF THE INDUSTRY |
16 |
|
REGULATORY ENVIRONMENT |
17 |
|
LIQUID CHROMATOGRAPHY IN BIOTECHNOLOGY |
18 |
|
MARKET VALUE |
18 |
|
TABLE 9 U.S. MARKET VALUE FOR LIQUID CHROMATOGRAPHY USED IN BIOTECHNOLOGY, THROUGH 2008 ($ MILLIONS) |
19 |
|
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY |
19 |
|
Ion Exchange Chromatography |
19 |
|
Hydroxyapatite Chromatography |
20 |
|
Size Exclusion Chromatography |
20 |
|
THIN LAYER CHROMATOGRAPHY |
20 |
|
AFFINITY CHROMATOGRAPHY |
21 |
|
OTHERS |
21 |
|
VARIABLES |
22 |
|
TABLE 10 CHROMATOGRAPHIC VARIABLES |
22 |
|
COMPONENTS |
23 |
|
MODES |
24 |
|
FIGURE 9 U.S. MARKET SHARES OF BIOTECH CHROMATOGRAPHY MODES, 2003 (%) |
24 |
|
TABLE 11 U.S. BIOTECH CHROMATOGRAPHY MODES MARKET VALUE, 2003 ($ MILLIONS) |
25 |
|
Process Development |
25 |
|
FIGURE 10 U.S. MARKET SHARES OF BIOTECH LC PROCESS DEVELOPMENTS, 2003 |
26 |
|
TABLE 12 U.S. BIOTECH LC PROCESS DEVELOPMENTS MARKET VALUE, 2003 ($ MILLIONS) |
27 |
|
Analytical-Scale |
27 |
|
Preparative-Scale |
27 |
|
Process-Scale |
27 |
|
APPLICATIONS |
28 |
|
FIGURE 11 U.S. MARKET SHARES OF BIOTECH CHROMATOGRAPHIC APPLICATIONS, 2003 |
28 |
|
TABLE 13 U.S. BIOTECH CROMATOGRAPHIC APPLICATIONS MARKET VALUE, 2003 ($ MILLIONS) |
29 |
|
PROTEINS |
29 |
|
Protein Purification |
30 |
|
Proteinaceous Aggregates |
30 |
|
Protein Recovery |
30 |
|
Multimeric Proteins |
30 |
|
Protein Fractionation |
31 |
|
Therapeutic Proteins |
31 |
|
Nucleic Acids |
31 |
|
DNA Sequencing |
31 |
|
Mutated DNA |
32 |
|
DNA Triple Repeat Sequences |
33 |
|
Polynucleotide Separations |
33 |
|
SNP Separations |
33 |
|
Oligonucleotide Purification |
33 |
|
Trace Aggregations |
34 |
|
Peptides |
34 |
|
ANTIBODIES |
34 |
|
Monoclonal Antibodies |
34 |
|
Antibody Proteins |
35 |
|
OTHERS |
35 |
|
Enzymes |
36 |
|
Hormones |
36 |
|
Enantiomers |
36 |
|
Mirror-Image Isomers |
36 |
|
Racemate Mixtures |
37 |
|
Virus Particles |
37 |
|
Endotoxin Reduction |
37 |
|
Gene Therapy |
38 |
|
Drug Screening |
38 |
|
Blood Substitute |
39 |
|
STRUCTURE OF THE INDUSTRY |
39 |
|
FIGURE 12 U.S. MARKET SHARES OF BIOTECH CHROMATOGRAPHY SUPPLIERS, 2003 (%) |
40 |
|
TABLE 14 U.S. BIOTECH CHROMATOGRAPHY SUPPLIERS MARKET VALUE, 2003 ($ MILLIONS) |
40 |
|
MAJOR PLAYERS |
41 |
|
Agilent Technologies, Inc. |
41 |
|
Applied Biosystems Group |
41 |
|
Gilson |
42 |
|
Waters Corp. |
42 |
|
MID-LEVEL PLAYERS |
42 |
|
Amersham Biosciences, Inc. |
43 |
|
Analtech |
43 |
|
Beckman Coulter, Inc. |
44 |
|
Cohesive Technologies, Inc. |
44 |
|
Bio-Rad Laboratories |
45 |
|
Dionex |
45 |
|
Eksigent Technologies |
46 |
|
Isco, Inc. |
46 |
|
Michrom Bioresources, Inc. |
46 |
|
PDR-Chiral, Inc. |
47 |
|
PerkinElmer, Inc. |
47 |
|
Richard Scientific |
47 |
|
Rohm and Haas Co. |
48 |
|
Shimadzu Scientific Instruments |
48 |
|
Transgenomic, Inc. |
48 |
|
Varian, Inc. |
49 |
|
Alltech Associates, Inc. |
49 |
|
Biotage |
50 |
|
Burdick & Jackson |
50 |
|
Chiral Technologies, Inc. |
50 |
|
Ciphergen Biosystems, Inc. |
51 |
|
Davison Chemicals |
51 |
|
Grace Vydac |
51 |
|
Hamilton Co. |
52 |
|
Hitachi, Ltd. |
52 |
|
Hodge Bioseparation, Ltd. |
52 |
|
Interaction Chromatography |
53 |
|
Integrated Separation Systems |
53 |
|
Ligochem |
53 |
|
Mettler-Toledo Instruments, Inc. |
54 |
|
Millipore Corp. |
54 |
|
Pall Corp. |
54 |
|
Phenomenex, Inc. |
55 |
|
Prolinx, Inc. |
55 |
|
Restek Corp. |
55 |
|
Sartorius Corp. |
56 |
|
Selerity Technologies, Inc. |
56 |
|
Sterogene Bioseparations, Inc. |
56 |
|
Supelco |
57 |
|
Thermo Hypersil-Keystone |
57 |
|
Tosoh Biosep LLC |
57 |
|
UOP, LLC |
58 |
|
Upchurch Scientific |
58 |
|
Zirchrom Separations, Inc. |
58 |
|
CENTRIFUGATION IN BIOTECHNOLOGY |
59 |
|
MARKET VALUE |
59 |
|
TABLE 15 U.S. BIOTECH CENTRIFUGATION MARKET VALUE, THROUGH 2008 ($ MILLIONS) |
60 |
|
SMALL-SCALE |
60 |
|
LARGE-SCALE |
61 |
|
APPLICATIONS |
61 |
|
FIGURE 13 U.S. MARKET SHARE OF BIOTECH CENTRIFGUATION APPLICATIONS, 2003 (%) |
62 |
|
TABLE 16 U.S. BIOTECH CENTRIFUGAL APPLICATIONS MARKET VALUE, 2003 ($ MILLIONS) |
62 |
|
FERMENTATION ISOLATIONS |
63 |
|
Dewatering |
63 |
|
Cell Separations |
63 |
|
Cell Debris Removal |
63 |
|
Bacterial Cells |
64 |
|
Whole Cells |
64 |
|
Animal Cells |
64 |
|
Cell Suspensions |
64 |
|
BLOOD FRACTIONATION |
65 |
|
RESTRICTION FRAGMENTS RECOVERY |
65 |
|
DNA Fragment Isolations |
65 |
|
Plasmids |
66 |
|
Large Fragments |
66 |
|
Subcellular Particles |
66 |
|
OTHERS |
66 |
|
STRUCTURE OF THE INDUSTRY |
67 |
|
FIGURE 14 U.S. MARKET SHARE OF U.S. BIOTECH CENTRIFUGE SUPPLIERS, 2003 |
67 |
|
TABLE 17 U.S. BIOTECH CENTRIFUGE SUPPLIERS MARKET VALUE, 2003 ($ MILLIONS) |
68 |
|
MAJOR PLAYERS |
68 |
|
Alfa Laval, Inc. |
68 |
|
Beckman Coulter, Inc. |
69 |
|
Brinkmann Instruments, Inc. |
69 |
|
Kendro Laboratory Products, Inc. |
70 |
|
MID-LEVEL PLAYERS |
70 |
|
Bird Machine Co. |
70 |
|
Fiberlite Centrifuge, Inc. |
71 |
|
Fisher Scientific International, Inc. |
71 |
|
Jouan, Inc. |
72 |
|
LW Scientific, Inc. |
72 |
|
Thermo Forma |
72 |
|
MEMBRANE FILTRATION IN BIOTECHNOLOGY |
73 |
|
MARKET VALUE |
73 |
|
TABLE 18 U.S. MARKET VALUE OF MEMRANE FILTRATION IN BIOTECHNOLOGY, THROUGH 2008 ($ MILLIONS) |
74 |
|
ULTRAFILTRATION |
75 |
|
MICROFILTRATION |
75 |
|
PROCESS SIZES |
76 |
|
TABLE 19 PROGRESSIVE STEPS FOR MEMBRANE SCALE-UP |
76 |
|
FIGURE 15 U.S. MARKET SHARE OF MEMBRANE FILTRATION PROCESS SIZES, 2003 (%) |
77 |
|
TABLE 20 U.S. MARKET VALUE OF MEMBRANE FILTRATION PROCESS SIZES, 2003 ($ MILLIONS) |
77 |
|
OPERATING MODES OF OPERATION |
78 |
|
FIGURE 16 U.S. MARKET SHARE OF MEMBRANE FILTRATION OPERATING MODES, 2003 (%) |
79 |
|
TABLE 21 U.S. MARKET VALUE OF MEMBRANE FILTRATION OPERATING MODES, 2003 ($ MILLIONS) |
79 |
|
MEMBRANE CONFIGURATIONS |
80 |
|
FIGURE 17 U.S. MARKET SHARE OF MEMBRANE FILTRATION CONFIGURATIONS, 2003 (%) |
81 |
|
TABLE 22 U.S. MEMBRANE FILTRATION CONFIGURATIONS MARKET VALUE, 2003 ($ MILLIONS) |
81 |
|
TABLE 23 CONFIGURATION ADVANTAGES IN BIOTECHNOLOGY |
82 |
|
APPLICATIONS |
83 |
|
FIGURE 18 U.S. MARKET SHARE OF MEMBRANE FILTRATION, BY PROCESSING TYPE, 2003 (%) |
83 |
|
TABLE 24 U.S. MARKET VALUE OF MEMBRANE FILTRATION, BY PROCESSING TYPE, 2003 ($ MILLIONS) |
84 |
|
UPSTREAM |
84 |
|
DOWNSTREAM PROCESSING |
84 |
|
Cell Separations |
85 |
|
Concentration |
85 |
|
Mammalian Cell Concentrations |
85 |
|
Harvesting |
85 |
|
Culture |
86 |
|
Protein Separations |
86 |
|
Blotting |
87 |
|
Electrostatic Self-Assembly |
87 |
|
STRUCTURE OF THE INDUSTRY |
88 |
|
FIGURE 19 U.S. MARKET SHARE OF BIOTECH MEMBRANE FILTRATION SUPPLIERS, 2003 (%) |
88 |
|
TABLE 25 U.S. MARKET VALUE OF MEMBRANE FILTRATION BIOTECH SUPPLIERS TIERS, 2003 ($ MILLIONS) |
89 |
|
MAJOR PLAYERS |
89 |
|
Millipore Corp. |
89 |
|
Pall Corp. |
90 |
|
MID-LEVEL PLAYERS |
90 |
|
Amersham Biosciences |
91 |
|
Cuno, Inc. |
91 |
|
GE Osmonics, Inc. |
91 |
|
Koch Membranes, Inc. |
92 |
|
S&S Microsciences |
92 |
|
OTHER SUPPLIERS |
92 |
|
Applied Membrane Technology |
93 |
|
CeraMem Separations |
93 |
|
Corning, Inc. |
93 |
|
Desalination Systems, Inc. |
94 |
|
Minntech Corp. |
94 |
|
Sartorius Corp. |
94 |
|
Spectrum Laboratories, Inc. |
94 |
|
ELECTROPHORESIS |
95 |
|
MARKET VALUE |
95 |
|
TABLE 26 U.S. MARKET VALUE OF ELECTROPHORESIS IN BIOTECHNOLOGY, THROUGH 2008 ($ MILLIONS) |
96 |
|
GEL/SLAB ELECTROPHORESIS PRINCIPLES |
96 |
|
FIGURE 20 SCHEMATIC OF AN ELECTROPHORESIS SEPARATION CELL |
97 |
|
CAPILLARY ELECTROPHORESIS |
98 |
|
ELECTROPHORETIC MODES |
98 |
|
ZONE |
98 |
|
TWO DIMENSIONAL |
99 |
|
ISOELECTRIC FOCUSING |
99 |
|
MOVING BOUNDARY |
99 |
|
FREE-FLOW/OPEN-CHAMBER-FLOW, OPEN-CHAMBER |
100 |
|
ISOTACHOPHORESIS |
100 |
|
DIFFERENCE GEL |
100 |
|
CAPILLARY GEL |
101 |
|
Combined Modes |
101 |
|
Capillary Electrochromatography |
101 |
|
Micellar Electrokinetic Capillary Chromatography |
102 |
|
Other Combinations |
102 |
|
APPLICATIONS |
102 |
|
FIGURE 21 U.S. MARKET SHARE OF BIOTECH ELECTROPHORESIS APPLICATIONS, 2003 (%) |
103 |
|
TABLE 27 U.S. BIOTECH ELECTROPHORESIS APPLICATIONS MARKET VALUE, 2003 ($ MILLIONS) |
103 |
|
DNA SEQUENCING |
104 |
|
DNA Fragments |
104 |
|
RDNA-Derived Products |
105 |
|
DNA Fingerprinting |
105 |
|
Crime-Scene Analysis |
105 |
|
Non-Sequencing |
106 |
|
Short Tandem Repeats |
106 |
|
SNP Detection |
106 |
|
Restriction Mapping |
107 |
|
PROTEINS |
107 |
|
Multiple Protein Fractions |
107 |
|
Liquid-Phase Protein Separation |
107 |
|
Expressed Proteins |
108 |
|
Peptides |
108 |
|
OTHERS |
108 |
|
Antibodies |
108 |
|
Chromosomes |
109 |
|
ALP Isoenzymes |
109 |
|
Gene Therapy |
109 |
|
STRUCTURE OF THE INDUSTRY |
109 |
|
FIGURE 22 U.S. MARKET SHARE OF BIOTECH ELECTROPHORESIS SUPPLIERS, 2003 (%) |
110 |
|
TABLE 28 U.S. BIOTECH ELECTROPHORESIS SUPPLIERS MARKET VALUE, 2003 ($ MILLIONS) |
111 |
|
MAJOR PLAYERS |
111 |
|
Amersham Biosciences |
111 |
|
Applied Biosystems |
112 |
|
Beckman Coulter, Inc. |
112 |
|
Bio-Rad |
113 |
|
MID-LEVEL PLAYERS |
113 |
|
Agilent Technologies, Inc. |
113 |
|
Caliper Technologies |
114 |
|
Invitrogen Corp. |
114 |
|
Spectrumedix |
115 |
|
Tecan, Inc. |
115 |
|
SUPPLIERS |
115 |
|
Apogee Designs, Ltd. |
115 |
|
CuraGen Corp. |
116 |
|
Diversified Biotech |
116 |
|
Genomics Solutions, Inc. |
116 |
|
Dionex Corp. |
117 |
|
Gradipore, Inc. |
117 |
|
Hitachi Chemical Co., Ltd. |
117 |
|
Lynx Therapeutics, Inc. |
118 |
|
MicroSolv Technology Corp. |
118 |
|
Millipore Corp. |
118 |
|
Phenomenex, Inc. |
119 |
|
PerkinElmer, Inc. |
119 |
|
NICHE BIOTECH SEPARATION TECHNOLOGIES |
120 |
|
TABLE 29 U.S. MARKET VALUE OF NICHE BIOTECH SEPARATION TECHNOLOGIES, THROUGH 2008 ($ MILLIONS) |
120 |
|
MICROARRAYS |
120 |
|
MARKET VALUE |
121 |
|
TABLE 30 U.S. MARKET VALUE OF BIOTECH MICROARRAY SEPARATIONS, THROUGH 2008 ($ MILLIONS) |
122 |
|
APPLICATIONS |
122 |
|
Nucleic Acids |
122 |
|
DNA Sequencing |
122 |
|
DNA Fingerprinting |
123 |
|
Forensic Analysis |
123 |
|
Oligonucleotide-based Probes |
123 |
|
Proteins |
124 |
|
Macromolecular Sequencing |
124 |
|
Protein Expression Profiling |
125 |
|
HIS-Tagged Protein Capture |
125 |
|
SARS Biomarkers |
125 |
|
Others |
125 |
|
STRUCTURE OF THE INDUSTRY |
126 |
|
Affymetrix, Inc. |
126 |
|
Agilent Technologies, Inc. |
126 |
|
Alpha Innotech Corp. |
127 |
|
Amersham Biosciences |
127 |
|
Applied Biosystems Group |
127 |
|
Biomicro Systems, Inc. |
128 |
|
Biosite, Inc. |
128 |
|
Bruker Daltonics, Inc. |
128 |
|
Caliper Technologies |
129 |
|
Ciphergen Biosystems, Inc. |
129 |
|
Illumina, Inc. |
130 |
|
Micronics, Inc. |
130 |
|
Nanogen, Inc. |
130 |
|
Panomics, Inc. |
131 |
|
PerkinElmer, Inc. |
131 |
|
Phylos, Inc. |
131 |
|
SemiBio Technology, Inc. |
132 |
|
SomaLogic, Inc. |
132 |
|
Tecan Boston |
132 |
|
Thermo Orion |
133 |
|
UT-Battelle, LLC |
133 |
|
LC/MS HYBRIDS |
133 |
|
MARKET VALUE |
134 |
|
TABLE 31 U.S. MARKET VALUE OF BIOTECH LC/MS HYBRID SYSTEMS, THROUGH 2008 ($ MILLIONS) |
134 |
|
APPLICATIONS |
135 |
|
Proteins |
135 |
|
Post-Translational Proteins |
135 |
|
Fractions |
135 |
|
Antibodies |
136 |
|
Plague Pathology |
136 |
|
Monitoring Bioprocesses |
136 |
|
Drug Profiling |
136 |
|
STRUCTURE OF THE INDUSTRY |
137 |
|
Advion Biosciences, Inc. |
137 |
|
Agilent Technologies, Inc. |
137 |
|
Amersham Biosciences |
138 |
|
Applied Biosystems Group |
138 |
|
Bruker Daltonics, Inc. |
139 |
|
Cetek Corp. |
139 |
|
Cohesive Technologies, Inc. |
139 |
|
Gilson, Inc. |
139 |
|
Jeol USA |
140 |
|
Kionix, Inc. |
140 |
|
Rheodyne, L.P. |
140 |
|
Shimadzu Scientific Instruments |
141 |
|
Thermo Finnigan |
141 |
|
Varian, Inc. |
142 |
|
Waters Corp. |
142 |
|
SPINNING SYSTEMS |
142 |
|
MARKET VALUE |
143 |
|
TABLE 32 U.S. MARKET VALUE OF BIOTECH SPINNING SYSTEMS, THROUGH 2008 ($ MILLIONS) |
143 |
|
APPLICATIONS |
144 |
|
STRUCTURE OF THE INDUSTRY |
144 |
|
Corning, Inc. |
145 |
|
Labconco Corp. |
145 |
|
Millipore Corp. |
146 |
|
Orbital Biosciences, LLC |
146 |
|
Pall Life Sciences |
146 |
|
Schleicher and Schuell Biosciences, Inc. |
147 |
|
SpinTek Systems |
147 |
|
Thermo Savant |
147 |
|
Vivascience, Inc. |
148 |
|
Whatman |
148 |
|
MAGNETIC SYSTEMS |
148 |
|
MARKET VALUE |
149 |
|
TABLE 33 U.S. MARKET VALUE OF BIOTECH MAGNETIC SEPARATIONS, THROUGH 2008 ($ MILLIONS) |
149 |
|
APPLICATIONS |
149 |
|
Proteins |
150 |
|
Cells |
150 |
|
Stem Cells |
150 |
|
Antibodies/Antigens |
151 |
|
STRUCTURE OF THE INDUSTRY |
151 |
|
Aviva Biosciences, Inc. |
151 |
|
Bangs Laboratories, Inc. |
152 |
|
Cortex Biochem, Inc. |
152 |
|
Dynal Biotech |
152 |
|
Gerstel, Inc. |
153 |
|
Polysciences, Inc. |
153 |
|
Promega Corp. |
153 |
|
Roche Applied Sciences |
154 |
|
Rocky Mountain Biosystems, Inc. |
154 |
|
SUPERCRITICAL FLUID CHROMATOGRAPHY |
154 |
|
TABLE 34 TYPICAL SFC MOBILE PHASES |
154 |
|
MARKET VALUE |
155 |
|
TABLE 35 U.S. MARKET VALUE OF BIOTECH SFC, THROUGH 2008 ($ MILLIONS) |
155 |
|
APPLICATIONS |
155 |
|
STRUCTURE OF THE INDUSTRY |
156 |
|
Mettler-Toledo Instruments, Inc. |
156 |
|
The Lavipharm Group |
156 |
|
Ontogen Corp. |
157 |
|
Selerity Technologies, Inc. |
157 |
|
Thar Technologies, Inc. |
157 |
|
APPENDICES |
158 |
|
A: MOLECULAR SEPARATIONS IN BIOTECHNOLOGY |
158 |
|
TABLE 36 SELECTED MOLECULAR SEPARATIONS NEEDED IN BIOTECHNOLOGY |
158 |
|
TABLE 36 (CONTINUED) |
159 |
|
TABLE 36 (CONTINUED) |
160 |
|
B: COMMON MATERIALS IN BIOLOGICAL FEED STREAMS |
160 |
|
TABLE 37 APPARENT DIMENSIONS OF SMALL PARTICLES |
160 |
LIST OF TABLES |
|
|
SUMMARY TABLE: |
|
|
U.S. SEPARATIONS FOR BIOTECHNOLOGY MARKET VALUE, THROUGH 2008 ($ MILLIONS) |
XXII |
|
TABLE 1 U.S. BIOTECH SEPARATIONS MARKET VALUE, BY GEOGRAPHICAL REGION, 2003 |
3 |
|
TABLE 2 U.S. BIOTECH SEPARATIONS MARKET VALUE, BY TYPE, 2003 |
4 |
|
TABLE 3 U.S. BIOTECH LC TECHNIQUES MARKET VALUE, BY TYPE, 2003 ($ MILLIONS) |
6 |
|
TABLE 4 U.S. BIOTECH CENTRIFUGATION MARKET VALUE, 2003 ($ MILLIONS) |
8 |
|
TABLE 5 U.S. BIOTECH MEMBRANE FILTRATION MARKET VALUE, 2003 ($ MILLIONS) |
9 |
|
TABLE 6 U.S. BIOTECH ELECTROPHORESIS MARKET VALUE, 2003 ($ MILLIONS) |
11 |
|
TABLE 7 U.S. BIOTECH MISCELLANEOUS MARKET VALUE, 2003 ($ MILLIONS) |
13 |
|
TABLE 8 PROCESSING STEPS AND TECHNIQUES |
16 |
|
TABLE 9 U.S. MARKET VALUE FOR LIQUID CHROMATOGRAPHY USED IN BIOTECHNOLOGY, THROUGH 2008 ($ MILLIONS) |
19 |
|
TABLE 10 CHROMATOGRAPHIC VARIABLES |
22 |
|
TABLE 11 U.S. BIOTECH CHROMATOGRAPHY MODES MARKET VALUE, 2003 ($ MILLIONS) |
25 |
|
TABLE 12 U.S. BIOTECH LC PROCESS DEVELOPMENTS MARKET VALUE, 2003 ($ MILLIONS) |
27 |
|
TABLE 13 U.S. BIOTECH CROMATOGRAPHIC APPLICATIONS MARKET VALUE, 2003 ($ MILLIONS) |
29 |
|
TABLE 14 U.S. BIOTECH CHROMATOGRAPHY SUPPLIERS MARKET VALUE, 2003 ($ MILLIONS) |
40 |
|
TABLE 15 U.S. BIOTECH CENTRIFUGATION MARKET VALUE, THROUGH 2008 ($ MILLIONS) |
60 |
|
TABLE 16 U.S. BIOTECH CENTRIFUGAL APPLICATIONS MARKET VALUE, 2003 ($ MILLIONS) |
62 |
|
TABLE 17 U.S. BIOTECH CENTRIFUGE SUPPLIERS MARKET VALUE, 2003 ($ MILLIONS) |
68 |
|
TABLE 18 U.S. MARKET VALUE OF MEMRANE FILTRATION IN BIOTECHNOLOGY, THROUGH 2008 ($ MILLIONS) |
74 |
|
TABLE 19 PROGRESSIVE STEPS FOR MEMBRANE SCALE-UP |
76 |
|
TABLE 20 U.S. MARKET VALUE OF MEMBRANE FILTRATION PROCESS SIZES, 2003 ($ MILLIONS) |
77 |
|
TABLE 21 U.S. MARKET VALUE OF MEMBRANE FILTRATION OPERATING MODES, 2003 ($ MILLIONS) |
79 |
|
TABLE 22 U.S. MEMBRANE FILTRATION CONFIGURATIONS MARKET VALUE, 2003 ($ MILLIONS) |
81 |
|
TABLE 23 CONFIGURATION ADVANTAGES IN BIOTECHNOLOGY |
82 |
|
TABLE 24 U.S. MARKET VALUE OF MEMBRANE FILTRATION, BY PROCESSING TYPE, 2003 ($ MILLIONS) |
84 |
|
TABLE 25 U.S. MARKET VALUE OF MEMBRANE FILTRATION BIOTECH SUPPLIERS TIERS, 2003 ($ MILLIONS) |
89 |
|
TABLE 26 U.S. MARKET VALUE OF ELECTROPHORESIS IN BIOTECHNOLOGY, THROUGH 2008 ($ MILLIONS) |
96 |
|
TABLE 27 U.S. BIOTECH ELECTROPHORESIS APPLICATIONS MARKET VALUE, 2003 ($ MILLIONS) |
103 |
|
TABLE 28 U.S. BIOTECH ELECTROPHORESIS SUPPLIERS MARKET VALUE, 2003 ($ MILLIONS) |
111 |
|
TABLE 29 U.S. MARKET VALUE OF NICHE BIOTECH SEPARATION TECHNOLOGIES, THROUGH 2008 ($ MILLIONS) |
120 |
|
TABLE 30 U.S. MARKET VALUE OF BIOTECH MICROARRAY SEPARATIONS, THROUGH 2008 ($ MILLIONS) |
122 |
|
TABLE 31 U.S. MARKET VALUE OF BIOTECH LC/MS HYBRID SYSTEMS, THROUGH 2008 ($ MILLIONS) |
134 |
|
TABLE 32 U.S. MARKET VALUE OF BIOTECH SPINNING SYSTEMS, THROUGH 2008 ($ MILLIONS) |
143 |
|
TABLE 33 U.S. MARKET VALUE OF BIOTECH MAGNETIC SEPARATIONS, THROUGH 2008 ($ MILLIONS) |
149 |
|
TABLE 34 TYPICAL SFC MOBILE PHASES |
154 |
|
TABLE 35 U.S. MARKET VALUE OF BIOTECH SFC, THROUGH 2008 ($ MILLIONS) |
155 |
|
TABLE 36 SELECTED MOLECULAR SEPARATIONS NEEDED IN BIOTECHNOLOGY |
158 |
|
TABLE 37 APPARENT DIMENSIONS OF SMALL PARTICLES |
160 |
LIST OF FIGURES |
|
|
SUMMARY FIGURE: |
|
|
U.S. SEPARATIONS FOR BIOTECHNOLOGY MARKET VALUE, THROUGH 2008 ($ MILLIONS) |
XXIII |
|
FIGURE 1 U.S. BIOTECH SEPARATIONS MARKET SHARES BY GEOGRAPHICAL REGION, 2003 (%) |
2 |
|
FIGURE 2 U.S. BIOTECH SEPARATIONS MARKET SHARES BY TYPE, 2003 |
4 |
|
FIGURE 3 U.S. BIOTECH LC TECHNIQUES MARKET SHARES, BY TYPE, 2003 |
5 |
|
FIGURE 4 U.S. BIOTECH CENTRIFUGATION MARKET SHARES BY TYPE, 2003 (%) |
7 |
|
FIGURE 5 U.S. BIOTECH MEMBRANE FILTRATION MARKET SHARES BY TYPE, 2003 |
9 |
|
FIGURE 6 U.S. BIOTECH ELECTROPHORESIS MARKET SHARES BY TYPE, 2003 (%) |
10 |
|
FIGURE 7 U.S. BIOTECH NICHE SEPARATION TECHNOLOGIES MARKET SHARES BY TYPE, 2003 (%) |
12 |
|
FIGURE 8 GENERAL SCHEME OF A BIOTECH SEPARATION |
15 |
|
FIGURE 9 U.S. MARKET SHARES OF BIOTECH CHROMATOGRAPHY MODES, 2003 (%) |
24 |
|
FIGURE 10 U.S. MARKET SHARES OF BIOTECH LC PROCESS DEVELOPMENTS, 2003 |
26 |
|
FIGURE 11 U.S. MARKET SHARES OF BIOTECH CHROMATOGRAPHIC APPLICATIONS, 2003 |
28 |
|
FIGURE 12 U.S. MARKET SHARES OF BIOTECH CHROMATOGRAPHY SUPPLIERS, 2003 (%) |
40 |
|
FIGURE 13 U.S. MARKET SHARE OF BIOTECH CENTRIFGUATION APPLICATIONS, 2003 (%) |
62 |
|
FIGURE 14 U.S. MARKET SHARE OF U.S. BIOTECH CENTRIFUGE SUPPLIERS, 2003 |
67 |
|
FIGURE 15 U.S. MARKET SHARE OF MEMBRANE FILTRATION PROCESS SIZES, 2003 (%) |
77 |
|
FIGURE 16 U.S. MARKET SHARE OF MEMBRANE FILTRATION OPERATING MODES, 2003 (%) |
79 |
|
FIGURE 17 U.S. MARKET SHARE OF MEMBRANE FILTRATION CONFIGURATIONS, 2003 (%) |
81 |
|
FIGURE 18 U.S. MARKET SHARE OF MEMBRANE FILTRATION, BY PROCESSING TYPE, 2003 (%) |
83 |
|
FIGURE 19 U.S. MARKET SHARE OF BIOTECH MEMBRANE FILTRATION SUPPLIERS, 2003 (%) |
88 |
|
FIGURE 20 SCHEMATIC OF AN ELECTROPHORESIS SEPARATION CELL |
97 |
|
FIGURE 21 U.S. MARKET SHARE OF BIOTECH ELECTROPHORESIS APPLICATIONS, 2003 (%) |
103 |
|
FIGURE 22 U.S. MARKET SHARE OF BIOTECH ELECTROPHORESIS SUPPLIERS, 2003 (%) |
110 |